Sun, Aug 25 5:08am

Compare GALT

Big Percentage Losers (1)


Galectin Therapeutics Inc [GALT]
$3.02 0.17 (5.33%)

GALT Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 190 Million
GALT Description

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.


Visit Website

GALT Earnings

EPS -0.06 P/E Ratio 0.00
Previous Earnings Fri, May 10, 2019
Latest Earnings Fri, Aug 9, 2019 (16 days ago) -14.20%

GALT Dividend

Yield --
Ex-Date --
Pay Date --
History --

GALT Charts

$2.94
1 Year
$6.98
Aug 23, 2019
Sep 20, 2018



Symbol Price Day % YTD %
GALT $3.02 -5.33% -21.76%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy